BMRN Biomarin Pharmaceutical margins

Relative Growth: Rel. Growth: 61

Relative Strength: Rel. Strength: 50

Relative Valuation: Rel. Valuation: 18

Relative Profitability: Rel. Profitability: 43

Gross margin

76.1%

Operating margin

4.4%

EBITDA margin

11.3%

Net margin

2.1%

At present, Biomarin Pharmaceutical reports a gross margin of 76.1%, an operating margin of 4.4%, an EBITDA margin of 11.3%, and a net margin of 2.1%. Operating margin had the largest decline, decreasing by 20.9 percentage points, while the other available margins also declined.

BMRN margin history

Gross, operating, EBITDA and net margin trends

Biomarin Pharmaceutical's margins averaged 78.72% gross, 13.57% operating, 19.16% EBITDA, and 11.74% net during the last 3 years. The current gross, operating, EBITDA, and net margins are each below their three-year averages.

BMRN margin expansion

Year-over-year margin changes in percentage points

Year over year, gross, operating, EBITDA, and net margins all declined, with operating margin showing the largest decrease at 20.9 percentage points.

Gross margin expansion

-3.5pp

Operating margin expansion

-20.9pp

EBITDA margin expansion

-19.2pp

Net margin expansion

-19.4pp

BMRN Gross margin

Across the last 3 years, Biomarin Pharmaceutical recorded an average gross margin of 78.72%. Biomarin Pharmaceutical's current gross margin is 76.1% and is 2.6 percentage points below its three-year average. The highest gross margin for Biomarin Pharmaceutical was 81.3% in Sep 2025, while the lowest was 76.1% in Jun 2026.

BMRN Operating margin

Over the last 3 years, Biomarin Pharmaceutical's operating margin averaged 13.57%. The current operating margin of 4.4% is 9.2 percentage points below its three-year average. During this period, operating margin reached a high of 25.3% in Jun 2025 and a low of 4.4% in Jun 2026.

BMRN EBITDA margin

Over the last 3 years, Biomarin Pharmaceutical's EBITDA margin averaged 19.16%. At present, Biomarin Pharmaceutical's current EBITDA margin is 11.3%, which is 7.9 percentage points below its three-year average. During this period, EBITDA margin reached a high of 30.5% in Jun 2025 and a low of 11.3% in Jun 2026.

BMRN Net margin

Across the last 3 years, Biomarin Pharmaceutical's net margin averaged 11.74%. The current net margin stands at 2.1%, 9.6 percentage points below its three-year average. Net margin was highest at 21.5% in Jun 2025 and lowest at 2.1% in Jun 2026.

BMRN margin group comparison

Margins compared with peer-group, industry and sector averages

Biomarin Pharmaceutical's gross margin of 76.1% is higher than the Healthcare sector average but lower than the industry average. Looking at the Healthcare sector average of 68.4%, Biomarin Pharmaceutical's gross margin is 11% higher.

BMRN margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is Biomarin Pharmaceutical's gross margin?

The current gross margin for BMRN is 76.1% as of Jun 30, 2026.

What is Biomarin Pharmaceutical's operating margin?

The current operating margin for BMRN is 4.4% as of Jun 30, 2026.

What is Biomarin Pharmaceutical's EBITDA margin?

As of Jun 30, 2026, BMRN has an EBITDA margin of 11.3%.

What is Biomarin Pharmaceutical's net margin?

For the period ending Jun 30, 2026, BMRN recorded a net margin of 2.1%.

What are the average margins of BMRN?

Biomarin Pharmaceutical's average margins over the last 3 years were 78.7% gross, 13.6% operating, 19.2% EBITDA, and 11.7% net.

What are the highest historical margins of BMRN?

Across the 5-year period, BMRN posted its highest margins at 81.3% gross in Sep 2025, 25.3% operating in Jun 2025, 30.5% EBITDA in Jun 2025, and 21.5% net in Jun 2025.

What are the lowest historical margins of BMRN?

Over the last 5 years, Biomarin Pharmaceutical's lowest margins were 74.5% gross in Dec 2021, -4.5% operating in Dec 2021, 2.6% EBITDA in Dec 2021, and -3.5% net in Dec 2021.